Healthcare provider profile · identity verified

Emily Ann Eickstaedt, AGNP

Nurse Practitioner · COLORADO SPRINGS, CO · NPI 1376214106

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	309	34
Gabapentin	Gabapentin	251	26
Pantoprazole Sodium	Pantoprazole Sodium	243	33
Levothyroxine Sodium	Levothyroxine Sodium	232	30
Trazodone Hcl	Trazodone Hcl	191	22
Amlodipine Besylate	Amlodipine Besylate	186	25
Sertraline Hcl	Sertraline Hcl	174	20
Fluticasone Propionate	Fluticasone Propionate	160	24
Buspirone Hcl	Buspirone Hcl	158	19
Furosemide	Furosemide	155	22
Metoprolol Succinate	Metoprolol Succinate	143	14
Losartan Potassium	Losartan Potassium	133	20
Rosuvastatin Calcium	Rosuvastatin Calcium	130	18
Eliquis	Apixaban	129	14
Famotidine	Famotidine	118	17
Montelukast Sodium	Montelukast Sodium	118	17
Potassium Chloride	Potassium Chloride	118	17
Lisinopril	Lisinopril	116	16
Citalopram Hbr	Citalopram Hydrobromide	111	14
Escitalopram Oxalate	Escitalopram Oxalate	110	14
Mirtazapine	Mirtazapine	106	13
Hydrochlorothiazide	Hydrochlorothiazide	103	suppressed
Omeprazole	Omeprazole	102	13
Duloxetine Hcl	Duloxetine Hcl	93	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	93	suppressed
Allopurinol	Allopurinol	88	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	88	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	87	suppressed
Tramadol Hcl	Tramadol Hcl	87	18
Alendronate Sodium	Alendronate Sodium	81	11
Jardiance	Empagliflozin	80	suppressed
Carvedilol	Carvedilol	79	suppressed
Metformin Hcl	Metformin Hcl	77	suppressed
Olanzapine	Olanzapine	74	suppressed
Memantine Hcl	Memantine Hcl	65	suppressed
Propranolol Hcl	Propranolol Hcl	63	suppressed
Ezetimibe	Ezetimibe	56	suppressed
Clopidogrel	Clopidogrel Bisulfate	55	suppressed
Oxycodone Hcl	Oxycodone Hcl	52	12
Dapagliflozin	Dapagliflozin Propanediol	50	suppressed
Meloxicam	Meloxicam	50	suppressed
Prazosin Hcl	Prazosin Hcl	50	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Mounjaro	Tirzepatide	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	14
Bupropion Xl	Bupropion Hcl	46	suppressed
Icosapent Ethyl	Icosapent Ethyl	46	suppressed
Rexulti	Brexpiprazole	46	suppressed
Spironolactone	Spironolactone	45	suppressed
Bupropion Hcl Sr	Bupropion Hcl	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Temazepam	Temazepam	42	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	40	suppressed
Pregabalin	Pregabalin	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Bumetanide	Bumetanide	37	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Lamotrigine	Lamotrigine	37	suppressed
Ozempic	Semaglutide	37	suppressed
Risperidone	Risperidone	36	suppressed
Spiriva Respimat	Tiotropium Bromide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	11
Baclofen	Baclofen	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Wegovy	Semaglutide	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Ibuprofen	Ibuprofen	25	11
Levetiracetam	Levetiracetam	25	suppressed
Ammonium Lactate	Ammonium Lactate	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Jantoven	Warfarin Sodium	23	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	23	17
Clonazepam	Clonazepam	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Prednisone	Prednisone	22	suppressed
Erythromycin	Erythromycin Base	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Atenolol	Atenolol	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Gemtesa	Vibegron	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Primidone	Primidone	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Celecoxib	Celecoxib	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Letrozole	Letrozole	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Prolia	Denosumab	17	11
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Nexletol	Bempedoic Acid	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Clonidine	Clonidine	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Phenytek	Phenytoin Sodium Extended	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Valsartan	Valsartan	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Clozapine	Clozapine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Topiramate	Topiramate	13	suppressed
Zenpep	Lipase/Protease/Amylase	13	suppressed
Acamprosate Calcium	Acamprosate Calcium	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Atropine Sulfate	Atropine Sulfate	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error